From genome to epigenome
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK
* To whom correspondence should be addressed. Tel: +44 1223494753; Fax: +44 1223494919; Email: amm{at}sanger.ac.uk
Received January 14, 2005; Revised February 10, 2005; Accepted February 17, 2005
The success of the human genome sequencing project has created wide-spread interest in exploring the human epigenome in order to elucidate how the genome executes the information it holds. Although all (nucleated) human cells effectively contain the same genome, they contain very different epigenomes depending upon cell type, developmental stage, sex, age and various other parameters. This complexity makes it intrinsically difficult to precisely define an epigenome, let alone the epigenome. What is clear, however, is that in order to unravel any epigenome, existing and novel high-throughput approaches on the DNA, RNA and protein levels need to be harnessed and integrated. Here, we review the current thinking and progress on how to get from the genome to the epigenome(s) and discuss some potential applications.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. He, S. Chang, J. Zhang, Q. Zhao, H. Xiang, K. Kusonmano, L. Yang, Z. S. Sun, H. Yang, and J. Wang MethyCancer: the database of human DNA methylation and cancer Nucleic Acids Res., January 11, 2008; 36(suppl_1): D836 - D841. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, A. J. Sasco, C. Fu, H. Xue, G. Guo, Z. Hua, Q. Zhou, Q. Jiang, and B. Xu Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination with MTHFR C677T Genetic Polymorphism in Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Pinsonneault, A. C. Papp, and W. Sadee Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors Hum. Mol. Genet., September 1, 2006; 15(17): 2636 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bibikova, E. Chudin, B. Wu, L. Zhou, E. W. Garcia, Y. Liu, S. Shin, T. W. Plaia, J. M. Auerbach, D. E. Arking, et al. Human embryonic stem cells have a unique epigenetic signature Genome Res., September 1, 2006; 16(9): 1075 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Coleman and A. G. Rivenbark Quantitative DNA Methylation Analysis: The Promise of High-Throughput Epigenomic Diagnostic Testing in Human Neoplastic Disease J. Mol. Diagn., May 1, 2006; 8(2): 152 - 156. [Full Text] [PDF] |
||||
![]() |
J. Cheong, Y. Yamada, R. Yamashita, T. Irie, A. Kanai, H. Wakaguri, K. Nakai, T. Ito, I. Saito, S. Sugano, et al. Diverse DNA Methylation Statuses at Alternative Promoters of Human Genes in Various Tissues DNA Res, January 1, 2006; 13(4): 155 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sadee and Z. Dai Pharmacogenetics/genomics and personalized medicine Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R207 - R214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meissner, A. Gnirke, G. W. Bell, B. Ramsahoye, E. S. Lander, and R. Jaenisch Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis Nucleic Acids Res., October 13, 2005; 33(18): 5868 - 5877. [Abstract] [Full Text] [PDF] |
||||





